QAB143

Showing 1 posts of 1 posts found.

Novartis’ COPD drug recommended for FDA approval

March 10, 2011
Sales and Marketing Arcapta Neohaler, COPD, Novartis, Onbrez Breezhaler, QAB143, chronic obstructive pulmonary disease, indacterol

Novartis has won the backing of an FDA advisory committee for its chronic obstructive pulmonary disease (COPD) treatment QAB149. The …

The Gateway to Local Adoption Series

Latest content